BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12892515)

  • 1. Raman spectral mapping in the assessment of axillary lymph nodes in breast cancer.
    Smith J; Kendall C; Sammon A; Christie-Brown J; Stone N
    Technol Cancer Res Treat; 2003 Aug; 2(4):327-32. PubMed ID: 12892515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients.
    Som D; Tak M; Setia M; Patil A; Sengupta A; Chilakapati CM; Srivastava A; Parmar V; Nair N; Sarin R; Badwe R
    Lasers Med Sci; 2016 Jan; 31(1):95-111. PubMed ID: 26552923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raman spectroscopy--a potential new method for the intra-operative assessment of axillary lymph nodes.
    Horsnell JD; Smith JA; Sattlecker M; Sammon A; Christie-Brown J; Kendall C; Stone N
    Surgeon; 2012 Jun; 10(3):123-7. PubMed ID: 22525413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
    Seyednejad N; Kuusk U; Wiseman SM
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings].
    Cserni G; Boross G; Baltás B
    Orv Hetil; 1998 Aug; 139(32):1899-903. PubMed ID: 9731445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the intra-operative use of Raman spectroscopy in breast cancer-overcoming the effects of theatre lighting.
    Horsnell JD; Kendall C; Stone N
    Lasers Med Sci; 2016 Aug; 31(6):1143-9. PubMed ID: 27220528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
    Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
    J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in early breast cancer: the first 100 cases performed in a teaching institute.
    Mahajna A; Hershko DD; Israelit S; Abu-Salih A; Keidar Z; Krausz MM
    Isr Med Assoc J; 2003 Aug; 5(8):556-9. PubMed ID: 12929292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is axillary reverse mapping feasible in breast cancer patients?
    Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
    Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
    Jing X; Wey E; Michael CW
    Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
    Wolberg WH; Street WN
    Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
    Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
    Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
    Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
    Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is intra-operative nodal assessment essential in a modern breast practice?
    Benson JR; Wishart GC
    Eur J Surg Oncol; 2010 Dec; 36(12):1162-4. PubMed ID: 20880663
    [No Abstract]   [Full Text] [Related]  

  • 17. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
    Rutgers EJ
    J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
    Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
    Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.